Overview Quetiapine in Postpartum Depression Status: Terminated Trial end date: 2008-10-01 Target enrollment: Participant gender: Summary The purpose of the study is to evaluate the efficacy and tolerability of quetiapine in female patients with postpartum depressive disorder with psychotic symptoms Phase: Phase 2 Details Lead Sponsor: AstraZenecaTreatments: Quetiapine Fumarate